The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
Blood Cancer J
.
2011 Oct;1(10):e41.
doi: 10.1038/bcj.2011.42.
Epub 2011 Oct 28.
Authors
M S van der Veer
,
M de Weers
,
B van Kessel
,
J M Bakker
,
S Wittebol
,
P W H I Parren
,
H M Lokhorst
,
T Mutis
PMID:
22829073
PMCID:
PMC3255255
DOI:
10.1038/bcj.2011.42
No abstract available